Bottom line
TSINX vs SCHF: the short answer
TSINX (T. Rowe Price Spectrum International Equity Fund) and SCHF (Schwab International Equity ETF) are both mutual funds.
But SCHF is far broader, holding 1,479 positions to 12 for TSINX, so beyond the top names it adds exposure TSINX doesn't have.
SCHF is cheaper at 0.03% vs 0.74% — a difference of $71 a year per $10,000 invested.
Over one year, TSINX returned +30.4% vs +3.5% for SCHF (reporting dates differ).
Updated Nov 19, 2026
TSINX vs SCHF side by side
| TSINX | SCHF | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | T. Rowe Price | Schwab |
| Category | International Stock | International Stock |
| Expense ratio | 0.74% | 0.03% |
| Annual cost per $10k | $74 | $3 |
| 10-yr cost on $10k (prospectus) | $918 | $39 |
| Max front load | — | None |
| 12b-1 fee | — | — |
| 1-yr return | +30.4% | +3.5% |
| 5-yr return (annualized) | — | +5.0% |
| 10-yr return (annualized) | — | +5.4% |
| Best quarter | +18.9% | +17.0% |
| Worst quarter | −23.2% | −23.1% |
| Net assets (fund) | $1.4B | $66.5B |
| Number of holdings | 12 | 1,479 |
| Portfolio turnover | 14% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
TSINX and SCHF share none of their top holdings.
TSINX top 10
- Trp Intl Value Equity Fd-z — 22.06%
- Trp Intl Stock Fd-z — 17.95%
- Trp European Stock-z — 13.19%
- Trp New Asia-z — 12.56%
- Trp Overseas Stock Fd-z — 12.36%
- Trp International Discovery-z — 6.00%
- Trp Em Mkts Discovery Stk Fd-z Cl — 4.86%
- Trp Japan-z — 4.57%
- Trp Emer Mkts Stock Fd-z — 4.53%
- Trp Latin America-z — 0.95%
SCHF top 10
- Samsung Electronics Co Ltd — 3.32%
- SK hynix Inc — 2.81%
- ASML Holding NV — 2.10%
- HSBC Holdings PLC — 1.08%
- Roche Holding AG — 0.99%
- Novartis AG — 0.97%
- AstraZeneca PLC — 0.93%
- Royal Bank of Canada — 0.90%
- Nestle SA — 0.88%
- Shell PLC — 0.80%
FAQ
What is the difference between TSINX and SCHF?
Which is cheaper, TSINX or SCHF?
Should I own both TSINX and SCHF?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.